Current NDC auxiliary source row compounder:3891
This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.
Complete normalized row#
- Record Source
- ndc_compounder_zip
- Product Ndc Raw
- 70092-207
- Product Ndc
- 70092-207
- Product Ndc Digits
- 70092207
- Product Type Name
- HUMAN COMPOUNDED DRUG
- Proprietary Name
- Fent2mcg/ml-Ropiv0.1%PF 200ml NS- 250IVB
- Proprietary Name Suffix
- Nonproprietary Name
- Fent2mcg/ml-Ropiv0.1%PF 200ml NS- 250IVB
- Dosage Form Name
- INJECTION
- Route Name
- EPIDURAL
- Marketing Category Name
- OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
- Labeler Name
- QuVa Pharma, Inc.
- Establishment Name
- QuVa Pharma, Inc.
- Establishment Fei
- Substance Name
- FENTANYL CITRATE; ROPIVACAINE HYDROCHLORIDE
- Active Ingredients Info
- 400 ug/200 mL; 200 mg/200 mL
- History Active Ingredients Raw
- FENTANYL CITRATE; ROPIVACAINE HYDROCHLORIDE
- History Active Ingredients Info Raw
- 400 ug/200 mL; 200 mg/200 mL
- History Dosage Raw
- INJECTION
- Dea Schedule
- CII
- Package Ndc Raw
- 70092-207-37
- Package Ndc
- 70092-207-37
- Package Ndc Digits
- 7009220737
- Package Ndc11
- 70092020737
- Package Description
- 200 mL in 1 BAG (70092-207-37)
- Reporting Period Raw
- 2024-2
- Reporting Period
- 2024-2
- Normalization Status
- valid
- Source Archive
- compounders_ndc_directory.zip
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Last Modified
- Fri, 18 Sep 2026 15:17:23 GMT
- Source Archive Sha256
- 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
- Source Member Sha256
- f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
- Source Record Id
- compounder:3891
- Source Row Number
- 3891
- Source Row Hash
- 96304b055f60ee69a5b36732fbb5e607450e6e6125149d2f35bc6e71cb2c2864
- Import Run Id
- 20261116T204628Z
- Loaded At
- 2026-11-16 20:58:00
Exact raw FDA source fields#
{
"ROUTENAME": "EPIDURAL",
"PRODUCTNDC": "70092-207",
"DEASCHEDULE": "CII",
"LABELERNAME": "QuVa Pharma, Inc.",
"SUBSTANCENAME": "FENTANYL CITRATE; ROPIVACAINE HYDROCHLORIDE",
"DOSAGEFORMNAME": "INJECTION",
"NDCPACKAGECODE": "70092-207-37",
"PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
"PROPRIETARYNAME": "Fent2mcg/ml-Ropiv0.1%PF 200ml NS- 250IVB",
"REPORTINGPERIOD": "2024-2",
"NONPROPRIETARYNAME": "Fent2mcg/ml-Ropiv0.1%PF 200ml NS- 250IVB",
"PACKAGEDESCRIPTION": "200 mL in 1 BAG (70092-207-37) ",
"ACTIVEINGREDIENTSINFO": "400 ug/200 mL; 200 mg/200 mL",
"MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
"PROPRIETARYNAMESUFFIX": ""
}Normalization notes#
[]Current status projection#
- Dataset
- compounder
- Record Source
- ndc_compounder_zip
- Source Record Id
- compounder:3891
- Source Row Number
- 3891
- Status Scope
- package
- Lookup Ndc
- 70092-207-37
- Lookup Ndc Digits
- 7009220737
- Product Ndc
- 70092-207
- Product Ndc Digits
- 70092207
- Package Ndc
- 70092-207-37
- Package Ndc Digits
- 7009220737
- Package Ndc11
- 70092020737
- Product Id
- Status Code
- COMPOUNDER
- Status Label
- Outsourcing facility compounded drug report
- Reporting Period Raw
- 2024-2
- Reporting Period
- 2024-2
- Source Table
- fda_ndc_aux_compounder
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Row Hash
- 96304b055f60ee69a5b36732fbb5e607450e6e6125149d2f35bc6e71cb2c2864
- Import Run Id
- 20261116T204628Z
- Loaded At
- 2026-11-16 20:58:00